Corcept Therapeutics
Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
As of today, Corcept Therapeutics(CORT) shares are valued at $33.87. The company's market cap stands at 3.6B, with a P/E ratio of 41.60.
On 2026-03-06, Corcept Therapeutics(CORT) stock traded between a low of $33.00 and a high of $34.18. Shares are currently priced at $33.87, which is +2.6% above the low and -0.9% below the high.
The Corcept Therapeutics(CORT)'s current trading volume is 1.21M, compared to an average daily volume of 1.71M.
In the last year, Corcept Therapeutics(CORT) shares hit a 52-week high of $117.33 and a 52-week low of $28.66.
In the last year, Corcept Therapeutics(CORT) shares hit a 52-week high of $117.33 and a 52-week low of $28.66.
CORT News
Advertisement Earnings and legal developments reshape the Corcept Therapeutics (CORT) story Corcept Therapeutics (CORT) is back in focus after investors diges...
Corcept Therapeutics CORT has been witnessing steady demand for its sole marketed drug, Korlym (mifepristone), which is approved for the treatment of Cushing’s...
In February 2026, Corcept Therapeutics reported that full-year 2025 net income fell to US$99.65 million from US$141.21 million a year earlier, while guiding 202...
Analyst ratings
71%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.